Blog
Implied Volatility Surging for C.H. Robinson Worldwide Stock Options
Investors in C.H. Robinson Worldwide, Inc. CHRW need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $160 Put had some of the
Petrobras Awards AKOFS Offshore $246 Million Vessel Contract
Petrobras PBR is advancing its offshore growth and operational excellence strategy by awarding a $246 million contract to AKOFS Offshore, a provider of vessel-based subsea well construction and
Globant Launches GEAI 2.3 to Integrate Agentic Commerce Protocol
Globant S.A. GLOB has announced the release of version 2.3 of its proprietary AI platform, Globant Enterprise AI (GEAI). The latest move marks a major advancement with the integration of the Agentic
Do Options Traders Know Something About Pampa Energia Stock We Don't?
Investors in Pampa Energía S.A. PAM need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $40 Call had some of the highest implied
The Zacks Analyst Blog Highlights Reddit and Meta Platforms
For Immediate Release
Chicago, IL – October 8, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Implied Volatility Surging for Ameriprise Financial Stock Options
Investors in Ameriprise Financial, Inc. AMP need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $280 Call had some of the highest
Are Options Traders Betting on a Big Move in News Corporation Stock?
Investors in News Corporation NWSA need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $15 Put had some of the highest implied
Why Investors Need to Take Advantage of These 2 Oils and Energy Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
We know
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the
Why Investors Need to Take Advantage of These 2 Utilities Stocks Now
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the
Want Better Returns? Don't Ignore These 2 Oils and Energy Stocks Set to Beat Earnings
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Despite Fast-paced Momentum, Ford Motor (F) Is Still a Bargain Stock
Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and
How to Boost Your Portfolio with Top Basic Materials Stocks Set to Beat Earnings
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Consumer Discretionary Names
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Jackson Financial (JXN) Is Attractively Priced Despite Fast-paced Momentum
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Recent Price Trend in FitLife Brands (FTLF) is Your Friend, Here's Why
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the
Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings
Pfizer PFE is one of the largest and most successful drugmakers in oncology. It boasts a strong portfolio of approved cancer medicines as well as a robust pipeline of cancer candidates with a focus
The Zacks Analyst Blog Highlights CoreWeave, Meta Platforms, Microsoft and Nebius
For Immediate Release
Chicago, IL – October 8, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Are Options Traders Betting on a Big Move in CME Group Stock?
Investors in CME Group Inc. CME need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $220.00 Call had some of the highest implied
Is the Options Market Predicting a Spike in Ameren Stock?
Investors in Ameren Corporation AEE need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $50.00 Put had some of the highest implied
Are Tesla's "Affordable" Models Truly Cheap and Can They Fuel Demand?
After years of delays, Tesla TSLA has finally rolled out new “affordable” models. But these are just more affordable versions of its popular Model 3 and Model Y. The move comes as the EV pioneer
3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal
Late last month, Pfizer PFE announced a landmark deal with the Trump administration to cut drug prices and expand U.S. innovation and manufacturing.
Under the deal, Pfizer agreed to slash prices of



